Protecting Patients Starts with Safe Transfusions
A Simple Step That Can Save a Life
Blood transfusions are one of the most powerful tools in modern medicine. They help people recover from surgery, fight cancer, survive trauma, and manage chronic conditions. However, even something so life-giving can carry hidden risks.
One of the most serious is Transfusion-Associated Graft-Versus-Host Disease (TA-GVHD), a rare complication where immune cells from donated blood attack the recipient’s body. It’s devastating, often fatal, and tragically, there’s no cure once it begins.
The good news is that TA-GVHD is preventable.
By irradiating blood before transfusion, we can stop those donor immune cells from causing harm. It’s a small step in the process, but it makes a world of difference. It’s the kind of protection that doesn’t just meet a standard, it saves lives. Whether you’re working in a hospital, a lab, or supporting patients behind the scenes, blood irradiation is one of the most important safeguards we have. It’s why we’ve dedicated ourselves to making that process as reliable, efficient, and easy as possible.
Our Solution? The RS® 3400
The RS 3400® is our latest x-ray blood irradiator. It’s engineered to deliver unmatched dose uniformity, productivity, and ease of use. Built on our patented QUASTAR® Photonic Decontamination™ Technology, the RS® 3400 ensures consistent inactivation of T-lymphocytes in donor blood, helping you protect every patient, every time.
- US FDA 510(k) cleared medical device
- Manufactured and tested in Buford, Georgia, USA
- Compliant with 21 CFR 1020.40 radiation safety standards
- Redundant safety interlocks and ultra-low external emission
Latest News & Studies
Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR
Abstract: Common chromosomal fragile sites are unstable genomic loci susceptible to breakage, rearrangement, and are highly recombinogenic. Frequent alterations at these loci in tumor cells led to the hypothesis that they may...
Passive and Active Mechanisms Trap Activated CD8+ T Cells in the Liver
Abstract: The liver is a site where activated CD8(+) T cells are trapped and destroyed at the end of an immune response. The intrahepatic accumulation of activated murine TCR transgenic CD8(+) T cells was significantly reduced...